Annals of Otology Rhinology & Laryngology · 2004 · 45 citations · 35 references
Life SciencesImmunologyPathologyApoptosisImmunopathologyInflammationApoptosis In Immune CellsApoptotic SignalingEosinophilic DisordersNasal PhysiologyNasal PolyposisNasal PolypsEosinophil RecruitmentGlucocorticoid ImmunoregulationGlucocorticoid ImmunosuppressionGlucocorticoid Mechanism Of ActionGlucocorticoid Regulation Of InflammationGlucocorticoid-mediated Immune ModulationNasal-associated Lymphoid TissueTherapeutic Corticosteroids
Glucocorticoids are known to be effective in the treatment of nasal polyps (NPs). To examine the mechanisms of their effect, we evaluated 1) the ability of glucocorticoids to induce the apoptosis of eosinophils and T lymphocytes in NPs, and 2) the ability of dexamethasone to down-regulate epithelial cell functions that relate to eosinophilic inflammation. In vitro and in vivo, glucocorticoids increased the apoptosis of both eosinophils and T lymphocytes in NPs. Dexamethasone inhibited the production of granulocyte-macrophage colony-stimulating factor (GM-CSF) from both NP epithelial cells that were unstimulated and NP epithelial cells that were stimulated with interleukin-4 or tumor necrosis factor alpha. These results suggest that the clinical efficacy of glucocorticoids on NPs may be due to 1) induction of apoptosis in both eosinophils and T lymphocytes that infiltrate NPs, and 2) down-regulation of epithelial GM-CSF production, which prolongs eosinophil survival.
35
Fotini Paliogianni, A Raptis, Seema S. Ahuja et al. · Journal of Clinical Investigation · 1993 · 209 citations · Full text